Investigative Magnetic Resonance Imaging

Korean Society of Magnetic Resonance in Medicine (대한자기공명의과학회)
권호 표지
DOI QR코드

DOI QR Code

Guidelines for Cardiovascular Magnetic Resonance Imaging from the Korean Society of Cardiovascular Imaging (KOSCI) - Part 3: Perfusion, Delayed Enhancement, and T1- and T2 Mapping

  • Im, Dong Jin (Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine) ;
  • Hong, Su Jin (Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine) ;
  • Park, Eun-Ah (Department of Radiology, Seoul National University Hospital) ;
  • Kim, Eun Young (Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jo, Yeseul (Department of Radiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jeong Jae (Department of Radiology, Jeju National University Hospital) ;
  • Park, Chul Hwan (Department of Radiology and Research Institute of Radiological Science, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Yong, Hwan Seok (Department of Radiology, Korea University Guro Hospital) ;
  • Lee, Jae Wook (Department of Radiology, Soonchunhyang University Bucheon Hospital) ;
  • Hur, Jee Hye (Department of Radiology, Hanil General Hospital) ;
  • Yang, Dong Hyun (Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Bae-Young (Department of Radiology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2019.10.23
  • Accepted : 2019.10.29
  • Published : 2020.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

This document is the third part of the guidelines for the interpretation and post-processing of cardiac magnetic resonance (CMR) studies. These consensus recommendations have been developed by a Consensus Committee of the Korean Society of Cardiovascular Imaging (KOSCI) to standardize the requirements for image interpretation and post-processing of CMR. This third part of the recommendations describes tissue characterization modules, including perfusion, late gadolinium enhancement, and T1- and T2 mapping. Additionally, this document provides guidance for visual and quantitative assessment, consisting of "What-to-See," "How-To," and common pitfalls for the analysis of each module. The Consensus Committee hopes that this document will contribute to the standardization of image interpretation and post-processing of CMR studies.

Keywords

References

  1. Coelho-Filho OR, Rickers C, Kwong RY, Jerosch-Herold M. MR myocardial perfusion imaging. Radiology 2013;266:701-715 https://doi.org/10.1148/radiol.12110918
  2. Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 2013;15:35 https://doi.org/10.1186/1532-429X-15-35
  3. Min JY, Ko SM, Song IY, Yi JG, Hwang HK, Shin JK. Comparison of the diagnostic accuracies of 1.5T and 3T stress myocardial perfusion cardiovascular magnetic resonance for detecting significant coronary artery disease. Korean J Radiol 2018;19:1007-1020 https://doi.org/10.3348/kjr.2018.19.6.1007
  4. Chung SY, Lee KY, Chun EJ, et al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven threevessel coronary artery disease. AJR Am J Roentgenol 2010;195:356-362 https://doi.org/10.2214/AJR.08.1839
  5. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953 https://doi.org/10.1056/NEJMoa012369
  6. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-557 https://doi.org/10.1016/s0735-1097(86)80181-4
  7. Maron MS, Olivotto I, Maron BJ, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-875 https://doi.org/10.1016/j.jacc.2009.04.072
  8. Kim YK, Park EA, Park SJ, et al. Non-ischemic perfusion defects due to delayed arrival of contrast material on stress perfusion cardiac magnetic resonance imaging after coronary artery bypass graft surgery. Korean J Radiol 2014;15:188-194 https://doi.org/10.3348/kjr.2014.15.2.188
  9. Tejani FH, Thompson RC, Kristy R, Bukofzer S. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study. Int J Cardiovasc Imaging 2014;30:979-989 https://doi.org/10.1007/s10554-014-0419-7
  10. Kovacs D, Pivonka R, Khosla PG, Khosla S. Effect of caffeine on myocardial perfusion imaging using single photon emission computed tomography during adenosine pharmacologic stress. Am J Ther 2008;15:431-434 https://doi.org/10.1097/MJT.0b013e31815aec1b
  11. Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:57 https://doi.org/10.1186/1532-429X-12-57
  12. Schwitter J, DeMarco T, Kneifel S, et al. Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. Circulation 2000;101:2696-2702 https://doi.org/10.1161/01.CIR.101.23.2696
  13. Kelle S, Graf K, Dreysse S, Schnackenburg B, Fleck E, Klein C. Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery. J Cardiovasc Magn Reson 2010;12:28 https://doi.org/10.1186/1532-429X-12-28
  14. Keelan PC, Bielak LF, Ashai K, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001;104:412-417 https://doi.org/10.1161/hc2901.093112
  15. Rieber J, Huber A, Erhard I, et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 2006;27:1465-1471 https://doi.org/10.1093/eurheartj/ehl039
  16. Kroll K, Wilke N, Jerosch-Herold M, et al. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 1996;271:H1643-1655
  17. Jerosch-Herold M, Swingen C, Seethamraju RT. Myocardial blood flow quantification with MRI by model-independent deconvolution. Med Phys 2002;29:886-897 https://doi.org/10.1118/1.1473135
  18. Ishida M, Schuster A, Morton G, et al. Development of a universal dual-bolus injection scheme for the quantitative assessment of myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011;13:28 https://doi.org/10.1186/1532-429X-13-28
  19. Christian TF, Aletras AH, Arai AE. Estimation of absolute myocardial blood flow during first-pass MR perfusion imaging using a dual-bolus injection technique: comparison to single-bolus injection method. J Magn Reson Imaging 2008;27:1271-1277 https://doi.org/10.1002/jmri.21383
  20. Gatehouse PD, Elkington AG, Ablitt NA, Yang GZ, Pennell DJ, Firmin DN. Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance. J Magn Reson Imaging 2004;20:39-45 https://doi.org/10.1002/jmri.20054
  21. Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging 1999;15:453-464 https://doi.org/10.1023/A:1006368619112
  22. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-514 https://doi.org/10.1081/JCMR-120022267
  23. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474 https://doi.org/10.1093/eurheartj/ehi258
  24. Lee JW, Jeong YJ, Lee G, et al. Predictive value of cardiac magnetic resonance imaging-derived myocardial strain for poor outcomes in patients with acute myocarditis. Korean J Radiol 2017;18:643-654 https://doi.org/10.3348/kjr.2017.18.4.643
  25. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453 https://doi.org/10.1056/NEJM200011163432003
  26. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-1638 https://doi.org/10.1016/j.jacc.2005.10.074
  27. Abbas A, Matthews GH, Brown IW, Shambrook JS, Peebles CR, Harden SP. Cardiac MR assessment of microvascular obstruction. Br J Radiol 2015;88:20140470 https://doi.org/10.1259/bjr.20140470
  28. Rajiah P, Desai MY, Kwon D, Flamm SD. MR imaging of myocardial infarction. Radiographics 2013;33:1383-1412 https://doi.org/10.1148/rg.335125722
  29. Saremi F, Grizzard JD, Kim RJ. Optimizing cardiac MR imaging: practical remedies for artifacts. Radiographics 2008;28:1161-1187 https://doi.org/10.1148/rg.284065718
  30. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383 https://doi.org/10.1002/mrm.10051
  31. Kellman P, Arai AE. Cardiac imaging techniques for physicians: late enhancement. J Magn Reson Imaging 2012;36:529-542 https://doi.org/10.1002/jmri.23605
  32. Farrelly C, Rehwald W, Salerno M, et al. Improved detection of subendocardial hyperenhancement in myocardial infarction using dark blood-pool delayed enhancement MRI. AJR Am J Roentgenol 2011;196:339-348 https://doi.org/10.2214/AJR.10.4418
  33. Bondarenko O, Beek AM, Hofman MB, et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-485 https://doi.org/10.1081/JCMR-53623
  34. Lim J, Park EA, Song YS, Lee W. Single-dose gadoterate meglumine for 3T late gadolinium enhancement mri for the assessment of chronic myocardial infarction: intraindividual comparison with conventional double-dose 1.5T MRI. Korean J Radiol 2018;19:372-380 https://doi.org/10.3348/kjr.2018.19.3.372
  35. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-2389 https://doi.org/10.1016/j.jacc.2004.09.020
  36. Flett AS, Hasleton J, Cook C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150-156 https://doi.org/10.1016/j.jcmg.2010.11.015
  37. Aljaroudi WA, Flamm SD, Saliba W, Wilkoff BL, Kwon D. Role of CMR imaging in risk stratification for sudden cardiac death. JACC Cardiovasc Imaging 2013;6:392-406
  38. Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92 https://doi.org/10.1186/1532-429X-15-92
  39. Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5:596-603 https://doi.org/10.1016/j.jcmg.2012.01.016
  40. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013;6:488-497 https://doi.org/10.1016/j.jcmg.2012.11.013
  41. Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013;6:392-398 https://doi.org/10.1161/CIRCIMAGING.112.000070
  42. Pedersen SF, Thrysoe SA, Robich MP, et al. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson 2012;14:59 https://doi.org/10.1186/1532-429X-14-59
  43. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-146 https://doi.org/10.1002/mrm.20110
  44. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708 https://doi.org/10.1148/radiology.211.3.r99jn41698
  45. Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M. T1 mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging 2016;9:67-81 https://doi.org/10.1016/j.jcmg.2015.11.005
  46. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson 2012;14:63 https://doi.org/10.1186/1532-429X-14-63
  47. Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 2013;6:373-383 https://doi.org/10.1161/CIRCIMAGING.112.000192
  48. Chen Y, Zheng X, Jin H, et al. Role of myocardial extracellular volume fraction measured with magnetic resonance imaging in the prediction of left ventricular functional outcome after revascularization of chronic total occlusion of coronary arteries. Korean J Radiol 2019;20:83-93 https://doi.org/10.3348/kjr.2018.0069
  49. Lee HG, Shim J, Choi JI, Kim YH, Oh YW, Hwang SH. Use of cardiac computed tomography and magnetic resonance imaging in case management of atrial fibrillation with catheter ablation. Korean J Radiol 2019;20:695-708 https://doi.org/10.3348/kjr.2018.0774
  50. Treibel TA, Fontana M, Maestrini V, et al. Automatic measurement of the myocardial interstitium: synthetic extracellular volume quantification without hematocrit sampling. JACC Cardiovasc Imaging 2016;9:54-63 https://doi.org/10.1016/j.jcmg.2015.11.008
  51. Shang Y, Zhang X, Zhou X, Wang J. Extracellular volume fraction measurements derived from the longitudinal relaxation of blood-based synthetic hematocrit may lead to clinical errors in 3 T cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2018;20:56 https://doi.org/10.1186/s12968-018-0475-6
  52. Kammerlander AA, Duca F, Binder C, et al. Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling: ready for prime time? Wien Klin Wochenschr 2018;130:190-196 https://doi.org/10.1007/s00508-017-1267-y
  53. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T1 measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 2013;70:664-670 https://doi.org/10.1002/mrm.24867
  54. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009;53:1475-1487 https://doi.org/10.1016/j.jacc.2009.02.007
  55. He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in ironoverloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med 2008;60:1082-1089 https://doi.org/10.1002/mrm.21744
  56. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179 https://doi.org/10.1053/euhj.2001.2822
  57. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation 2011;123:1519-1528 https://doi.org/10.1161/CIRCULATIONAHA.110.007641
  58. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968 https://doi.org/10.1161/CIRCULATIONAHA.109.874487